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摘要
目的:比较阻塞性睡眠窒息症(OSA)患者和正常人的图形
视网膜电图(PERG)和图形视觉诱发电位(PVEP)。
方法:前瞻性横断面研究。 研究包含马来西亚医科大学的
40 例 OSA 患者和 31 例正常人。 随机选取眼部未发生病
变并确诊 OSA的患者参与研究。 通过记录呼吸暂停低通
气指数(AHI)以用于对 OSA 的严重程度分层。 由马来西
亚医科大学眼科电生理实验室内训练有素的技术人员对
每位患者进行电生理检查(PVEP和 PERG)。 所得结果记
录为中位数。 使用 IBM Statistics Version 21. 0 完成数据
分析。
结果:在 OSA 患者中,与正常人相比,我们观察到 PERG
的 P50 振幅(P<0. 001)和 PVEP 的 P100 振幅(P<0. 001)
显著降低。 OSA患者 PVEP的 P100(P = 0. 003)和 N75 的
峰值时间(P=0. 004)均显著升高。 然而在 OSA患者和正
常人之间的 PERG 的峰值时间检测无显著差异。 在不同
疾病严重程度的 OSA 患者中 PVEP 或 PERG 也无显着
差异。
结论:OSA患者 PVEP幅度和峰值时间及 PERG 幅度存在
显著异常。 这可能反映了 OSA中的亚临床视神经功能障
碍。 需要进一步的研究来确定 OSA 的严重程度与视神经
功能障碍程度之间的关系。
关键词:阻塞性睡眠窒息症;呼吸暂停低通气指数;图形视
觉诱发电位;图形视网膜电图
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Abstract
誗AIM:To compare the pattern electroretinogram (PERG)
and pattern visual evoked potential ( PVEP ) between
obstructive sleep apnoea (OSA) patients and controls.
誗METHODS: This was a prospective cross - sectional
study involving 40 OSA patients and 31 control subjects in
Hospital Universiti Sains Malaysia. Patients with a
confirmed diagnosis of OSA who had no ocular pathology
were randomly selected to participate in the study. The
apnoea-hypopnoea index (AHI) was obtained from their
records and used for stratification of OSA severity.
Electrophysiological tests ( PVEP and PERG ) were
performed on each patient by a trained technician in the
electrophysiology laboratory of the Department of
Ophthalmology, USM. The results obtained were
recorded as median values. Data analysis was done using
IBM Statistics Version 21. 0.
誗 RESULTS: Among OSA patients, we observed a
significant reduction of the PERG amplitude P50 ( P <
0郾 001) and the PVEP amplitude P100 (P<0. 001) compared
to the control group. OSA patients also had a significant
increase in PVEP time to peak P100 (P= 0. 003) and time to
peak N75 (P= 0. 004) . However, no significant differences
were detected in PERG time to peak between OSA
patients and controls. There were likewise no significant
differences in PVEP or PERG between OSA patients with
different disease severity.
誗 CONCLUSION: OSA patients have significant
abnormalities in PVEP amplitude and time to peak, as
well as PERG amplitude. This may reflect subclinical optic
nerve dysfunction in OSA. Further research is needed to
determine the association between the severity of OSA
and the degree of optic nerve dysfunction.
誗 KEYWORDS: obstructive sleep apnoea; apnoea -
hypopnoea index; pattern visual evoked potential;
pattern electroretinogram
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INTRODUCTION
Obstructive sleep apnoea (OSA) is a life-threatening, sleep-
related breathing disorder in which the throat muscles relax
during sleep, causing soft tissue in the throat to collapse and
block the upper airway. This leads to partial ( hypopnoea)
and complete pauses (apnoea) in breathing that last at least
10 seconds during sleep. As a consequence, the blood oxygen
saturation may fall, with up to 40% decrease in oxygen levels
in severe cases[1] . Chronic oxygen deprivation results in
activation of the sympathetic pathway, vascular endothelial
dysfunction, increased oxidative stress, and inflammation,
which may contribute to the initiation and progression of
vascular diseases[2] . OSA has been shown to be associated
with an increased risk of systemic diseases including heart
failure[3], diabetes mellitus[4], sexual dysfunction[5],
cognitive decline[6] . In the eye, OSA has also been associated
with various conditions, particularly retinal and optic -nerve
related disorders[7-9] .
The visual evoked potential (VEP) is a measurement of the
electrical signal recorded at the scalp over the occipital cortex
in response to a stimulus, and reflects integrity of the afferent
visual pathway. The electroretinogram ( ERG) is a retinal
biopotential evoked by a stimulus of constant mean
luminance. In cases where the stimulus used is a
checkerboard, the VEP is termed a pattern VEP ( PVEP),
and the ERG likewise ( PERG). As the PERG is a local
response from the area stimulated by the retinal image, it
reflects the integrity of the optics, photo receptors, bipolar
cells and retinal ganglion cells, and can be a subtle indicator
of optic nerve dysfunction[10] . In OSA, optic neuropathy is
postulated to occur due to various mechanisms, including
increased intracranial pressure during apnoeic episodes, OSA-
induced hypoxia and increased levels of cytokines like
endothelin-1[11] . Thus, our study aims to evaluate optic nerve
function by comparing PVEP&PERG changes between patients
with OSA and the normal population.
SUBJECTS AND METHODS
This was a prospective cross - sectional study involving 40
obstructive sleep apnoea patients and 31 control subjects. It
was conducted in the Eye Clinic of Hospital Universiti Sains
Malaysia ( USM) between Jul. 2015 and Sep. 2016. The
conduct of the study followed the tenets of the declaration of
Helsinki.
Patients with OSA confirmed by overnight in - laboratory
polysomnography were randomly selected to participate in the
study. The inclusion criteria was visual acuity better than
6 / 12 and normal anterior and posterior segment findings.
Informed written consent was obtained from all patients. The
apnoea - hypopnoea index ( AHI ), which represents the
combined number of apnoeas and hypopnoeas that occur per
hour of sleep, was obtained from patients蒺 case notes and used
for stratification of OSA severity (mild OSA having an AHI of
5-15, moderate 16-30, and severe >30).
Ocular examination using slit lamp biomicroscopy ( Topcon
Corp, Japan) was performed to rule out ocular pathology,
which would have precluded participation in the study.
Intraocular pressure was assessed with Goldmann applanation
tonometry. Electrophysiological tests ( PVEP and PERG )
were performed on each patient by a trained technician in the
electrophysiology laboratory of the Department of
Ophthalmology, USM. The results obtained were recorded as
median values. The technique of PVEP and PERG conformed
to the International Society for Clinical Electrophysiology of
Vision recommendations.
All data was analysed using IBM SPSS Statistics version 21. 0.
For data which followed a normal distribution, mean values
were used for comparison, while in cases where the data was
not normally distributed, median values were utilised.
Statistical significance was taken as P<0. 05.
RESULTS
A total of 71 age - matched subjects were included in this
study. Of these, 40 had OSA (15 with mild, 9 with moderate
and 16 with severe OSA) while the remainder were control
subjects. Their other demographic and systemic features are
shown in Table 1.
Among OSA patients, we observed a significant reduction of
the PERG amplitude P50 (P<0. 001, Table 2) and the PVEP
amplitude P100(P<0. 001, Table 3) compared to the control
group. OSA patients also had a significant increase in PVEP
time to peak P100 (P = 0. 003) and time to peak N75(P =
0郾 004). However, no significant differences were detected in
PERG time to peak between OSA patients and controls.
There were no significant differences in PVEP or PERG
between OSA patients with different disease severity (Tables 4
and 5).
DISCUSSION
OSA is a sleep-related condition which has been associated
with systemic and ocular pathology, especially involving the
optic nerve[8,12-14] . Electrophysiological tests are useful to
assess the functional integrity of the afferent visual pathway
from the retina to the striate cortex[15-17] . To the best of our
knowledge, this study is the first to demonstrate significant
abnormalities in PVEP and PERG in OSA patients with no
ocular comorbidities.
We found that OSA patients had significant reduction of their
PVEP amplitude P100 and prolongation of time to peak P100
and time to peak N75. Our findings agree with those of
previous studies conducted in other populations[18-20] .
Abnormal VEP amplitude is suggestive of damage to optic
nerve axons[21] . We postulate that these findings are due to
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摇 摇Table 1摇 Demographic and systemic features of OSA and control group
Electrophysiology OSA patients (n=40) Control group (n=31) P
Mean age (SD) 45. 4(12. 2) 49. 3(16. 1) 0. 250a
Mean BMI (kg / m2) (SD) 33. 77(6. 62) 26. 15(1. 60) 0. 001a
Gender,n(% )
摇 M 27(71. 1) 11(28. 9) 0. 007b
Systemic disease (n,% )
摇 Hypertension 12 (66. 7) 6(33. 3) 0. 306b
摇 Diabetes 5 (83. 3) 1(16. 7) 0. 222c
摇 Hyperlipidaemia 12(66. 7) 6(33. 3) 0. 306b
Smoker (n,% ) 2(33. 3) 4(66. 7) 0. 393c
OSA: Obstructive sleep apnoea; BMI:Body mass index;a Independent t-test; bPearson Chi-square test; cFisher蒺s Exact Test.
Table 2摇 Comparison of mean PERG and PVEP between OSA and controls
Electrophysiology
OSA (n=40)
Mean(SD)
Control (n=31)
Mean(SD)
Mean diff(95% CI) t-statistics (df) aP
PERG amplitude N35 P50 2. 9(1. 02) 5. 6(0. 82) -2. 69(-3. 14,-2. 24) -11. 96(69) 0. 000a
PERG amplitude N95 P50 4. 7(1. 86) 8. 9(0. 98) -4. 26(-4. 94,-3. 57) -12. 40(62) 0. 000a
PERG time to peak N35 37. 0(4. 96) 37. 1(3. 05) -0. 98(-2. 00,1. 81) -0. 10(66) 0. 919
PVEP time to peak P100 118. 6(4. 01) 115. 6(4. 32) 3. 02(1. 04,5. 00) 3. 04(69) 0. 003a
OSA: Obstructive sleep apnoea; PERG: Pattern electroretinogram; PVEP: Pattern visual evoked potential. a Independent t-test.
Table 3摇 Comparison of median values of PERG and PVEP between OSA and controls
Electrophysiology
Median (IQR)
OSA (n=40) Control (n=31)
Z statistic aP
PERG time to peak P50 64. 37(4. 50) 64. 00(3. 00) -0. 691 0. 490
PERG time to peak N95 104. 50(9. 69) 101. 00(9. 00) -1. 073 0. 283
PVEP amplitude N75 P100 10. 22(6. 41) 18. 80(6. 28) -6. 168 <0. 001
PVEP amplitude N135 P100 7. 96(6. 63) 17. 90(4. 60) -5. 965 <0. 001
PVEP time to peak N75 84. 12(10. 25) 79. 00(5. 00) -2. 849 <0. 001
PVEP time to peak N135 146. 25(6. 88) 147. 00(9. 00) -1. 367 0. 172
OSA: Obstructive sleep apnoea; PERG: Pattern electroretinogram; PVEP: Pattern visual evoked potential; IQR: Interquartile range. aMann-
Whitney test.
hypoxic damage to the optic nerve secondary to repetitive
apnoeic episodes in OSA patients, resulting in ischemia and
damage to optic nerve axons.
Among OSA patients, we also observed a significant reduction
of the PERG amplitude P50 compared with the control group.
However, no significant differences in PERG time to peak
were observed between controls and OSA patients. These
findings differ from previous literature on this topic; Sergi et
al[20] observed that both amplitude and time to peak of PERG
were affected in OSA, while Liguori et al[19] found no
significant changes in either of these PERG parameters in
OSA. Moghimi et al[22] suggested that an abnormality in VEP
despite a normal ERG may be attributed to an early
pathological process that primarily affects the optic nerve,
sparing the retinal function. It is interesting to note that the
PERG has been found to be relatively normal in some
conditions ( e. g. demyelinating disease), while it may be
markedly abnormal in others ( e. g. ischaemic conditions) .
However, studies show that ischaemia tends to affect PERG
amplitude more than time to peak, and vice versa for
demyelination[10,15] . In our case, we believe that only the
amplitude was abnormal because OSA is predominantly a
condition of ischaemia.
Various authors have hypothesized that the underlying
pathophysiology of OSA involves chronic oxygen deprivation,
resulting in generalized sympathetic activation, vasculopathy,
oxidative stress and metabolic dysregulation, thus leading to
the increased risk of coronary artery disease, heart failure and
stroke observed in these conditions[23-25] . Ocular conditions
which have been attributed to this hypoxic theory in OSA
include non - arteritic ischaemic optic neuropathy[26-28] and
glaucoma[29-31] .
A recent study among patients with nonarteritic ischemic optic
neuropathy (NAION) found that the vast majority of them had
OSA[7-8] . The postulated mechanisms include direct exposure
of the optic nerve to OSA- induced hypoxia, hypoxia-induced
cerebral vasodilatation causing impaired optic
nerveautoregulation due to decreased cerebral perfusion
pressure, and impaired autoregulation[11] . Hypoxia has been
associated with imbalances in the vasoconstrictorendothelin-1
and vasodilator nitric oxide; the resulting vascular
dysregulation disrupts the normal blood flow in the retina and
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摇 摇Table 4摇 Comparison of mean PERG & PVEP between OSA patients with different disease severity
Electrophysiology OSA Severity by AHI Mean difference (95% CI) F statistic (df) aP
PERG
摇 Time to peak N35 (ms) Mild-moderate -2. 12 (-7. 43, 3. 19) 0. 525 (2) 0. 972
Mild-severe -0. 43 (-4. 96, 4. 10) 1. 000
Moderate-severe -1. 69 (-3. 56, 6. 94) 1. 000
摇 PERG amplitude N35 P50 (滋V) Mild-moderate 0. 16 (-0. 92, 1. 24) 0. 859 (2) 1. 000
Mild-severe 0. 48 (-0. 45, 1. 40) 0. 611
Moderate-severe 0. 31 (-0. 76, 1. 38) 1. 000
摇 PERG amplitude N95 P50 (滋V) Mild-moderate 0. 91 (-0. 99, 2. 82) 2. 249 (2) 0. 718
Mild-severe 1. 36 (-0. 26, 2. 99) 0. 128
Moderate-severe 0. 45 (-1. 43, 2. 34) 1. 000
PVEP
摇 Time to peak P100 (ms) Mild-moderate -1. 88 (-6. 12, 2. 36) 1. 019 (2) 0. 822
Mild-severe -1. 87 (-5. 48, 1. 75) 0. 611
Moderate-severe 0. 01 (-4. 18, 4. 20) 1. 000
摇 PVEP time to peak N135 (ms) Mild-moderate -1. 45 (-7. 09, 4. 19) 0. 333 (2) 1. 000
Mild-severe 0. 32 (-4. 49, 5. 12) 1. 000
Moderate-severe 1. 77 (-3. 80, 7. 33) 1. 000
摇 PVEP amplitude N75 P100 (滋V) Mild-moderate -2. 10 (-8. 33, 4. 14) 0. 385 (2) 1. 000
Mild-severe -0. 33 (-5. 65, 4. 98) 1. 000
Moderate-severe 1. 76 (-4. 40, 7. 93) 1. 000
摇 PVEP amplitude N135 P100 (滋V) Mild-moderate -1. 16 (-7. 48, 5. 15) 0. 113 (2) 1. 000
Mild-severe -0. 65 (-6. 03, 4. 73) 1. 000
Moderate-severe 0. 51 (-5. 72, 6. 75) 1. 000
OSA: Obstructive sleep apnoea; AHI: Apnoea-hypopnoea index; PERG: Pattern electroretinogram; PVEP: Pattern visual evoked potential.
aOne-Way ANOVA test.
Table 5摇 Comparison of median PERG & PVEP between OSA patients with different disease severity
Electrophysiology OSA Severity by AHI Median (IQR) X2(df) aP
PERG time to peak P50 (ms) Mild 64. 75 (3. 75) 0. 42(2) 0. 979
Moderate 64. 50 (4. 00)
Severe 62. 63 (6. 63)
PERG time to peak N95 (ms) Mild 104. 50 (4. 00) 0. 72(2) 0. 697
Moderate 104. 25 (19. 75)
Severe 104. 88 (15. 13)
PERG time to peak N75 (ms) Mild 87. 00 (9. 00) 6. 620(2) 0. 037
Moderate 87. 25 (8. 38)
Severe 79. 75 (15. 81)
OSA: Obstructive sleep apnoea; AHI: Apnoea-hypopnoea index; PERG: Pattern electroretinogram; PVEP: Pattern visual evoked potential;
IQR:Interquartile range. aKruskal-Wallis Test.
optic nerve head, thus potentially increasing the risk of
NAION[32-33] . Aptel et al[8] also observed that patients with
OSAS also had a higher risk of second eye involvement in
NAION. As a result, these authors have suggested that
polysomnography should be considered in patients with
NAION, and that therapeutic measures for OSA be undertaken
if polysomnography is diagnostic of OSA[8] .
The prevalence of glaucoma in OSA varies between studies,
from 5. 7% to 27% [34] . OSA may cause glaucomatous optic
neuropathy by creating transient hypoxemia and increasing
vascular resistance, thus resulting in compromised optic nerve
head perfusion and oxygenation. Kergoat et al[35] observed
that retinal ganglion cells are sensitive to even transient
episodes of hypoxia. Hypoxiais associated with an increase in
oxidative stress, subsequently lead to retinal ganglion cell
dysfunction[36] . Sergi et al[20] reported that the prevalence of
NTG was higher in OSA patients compared with controls.
Tsang et al[37] reported that moderate to severe OSA was
associated with a higher incidence of visual field defects and
glaucomatous changes in the optic nerve. Similarly, Moghimi
et al[22] reported that OSA patients had a higher prevalence of
glaucoma. Likewise, the prevalence of ocular hypertension
has been observed to be greater in OSA patients than in
controls[22] .
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The association between the AHI, which is a marker of the
severity of hypoxic damage, and the degree of ocular damage
objectively assessed by VEP and ERG, has been investigated
in various studies. Sergi et al[20] observed that AHI was
significantly greater in OSA patients with abnormal VEP and
PERG, compared to controls. Likewise, Guti佴rrez - D侏az et
al[18] found that in OSA patients with glaucoma, multifocal
VEP amplitude and latency were significantly correlated with
the AHI ( P < 0. 05 ). However, Liguori et al[19] had
conflicting results, as they failed to discover any correlation
between polysomnographic parameters and VEP or ERG
components in OSA patients. They explained their lack of
significance by the fact that their study only included a subset
of OSA patients, i. e. those with severe disease, who required
continuous positive airway pressure therapy[19] . Although we
stratified our patients蒺 disease severity based on the AHI, our
study did not demonstrate any significant association between
either PVEP or PERG with the severity of OSA.
Our study builds on the pre-existing literature by highlighting
PVEP and PERG abnormalities in asymptomatic patients with
OSA. This adds strength to the hypoxic theory in OSA. Early
identification and management of OSA may thus prevent
ongoing optic nerve damage. The fact that these abnormalities
were observed in patients with no ocular complaints suggests
that patients with OSA may potentially have undiagnosed optic
nerve dysfunction; if progressive, this subclinical damage may
eventually manifest as various ocular conditions. One of the
strengths of our study was that there were no significant
differences between the groups in terms of their age and
comorbidities. However, we concede that a limitation of our
study was the unequal numbers of subjects in each disease
severity group. Secondly, we were not able to perform the
electrophysiological tests at the time of OSA diagnosis, which
may explain the lack of significant association with disease
severity stratification, as the latter was based on an AHI
obtained at the time of diagnosis.
To conclude,OSA patients have significant abnormalities in
PVEP amplitude and time to peak, as well as PERG
amplitude. This may reflect subclinical optic nerve
dysfunction in OSA. Further research is needed to determine
the association between the severity of OSA and the degree of
optic nerve dysfunction.
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